| Home

Overview


Original Research

ABDOMINAL OBESITY AND ITS ASSOCIATED RISK FACTORS - AN UPDATE

BHASKAR CHARANA KABI 1, POOJA SHARMA 2, MANOJ KUMAR NANDKEOLIAR 3, RAJESH KUMAR THAKUR 4, DHIVYA S. 5, THURAYA ABDULLSALAM A. A. AL-AZAZI 6, and JASMEEN GUPTA 7.

Vol 18, No 11 ( 2023 )   |  DOI: 10.5281/zenodo.10153065   |   Author Affiliation: Professor, Department of Biochemistry, School of Medical Sciences and Research and Sharda Hospital, Sharda University, Greater Noida, Uttar Pradesh, India 1; M.Sc. Medical Biochemistry Final year, Department of Biochemistry, School of Medical Sciences and Research and Sharda Hospital, Sharda University, Greater Noida, Uttar Pradesh, India 2; Professor, Department of Biochemistry, School of Medical Sciences and Research and Sharda Hospital, Sharda University, Greater Noida, Uttar Pradesh, India 3; Associate Professor, Department of Biochemistry, School of Medical Sciences and Research and Sharda Hospital, Sharda University, Greater Noida, Uttar Pradesh, India 4; Assistant Professor, Department of Biochemistry, School of Medical Sciences and Research and Sharda Hospital, Sharda University, Greater Noida, Uttar Pradesh, India 5,6; Tutor and PhD Scholar, Department of Biochemistry, School of Medical Sciences and Research and Sharda Hospital, Sharda University, Greater Noida, Uttar Pradesh, India 7.   |   Licensing: CC 4.0   |   Pg no: 303-316   |   Published on: 18-11-2023

Abstract

Background: India has a serious Abdominal Obesity (AO) concern with a frequency of 24.8%, particularly among metropolitan especially in women. Generalised obesity (GO) & AO, both of which are associated with greater rates of mortality & morbidity. In India, AO is more prevalent than GO (24.5%), & it has been associated to a number of health hazards, including the metabolic syndrome, insulin resistance, & cardiovascular diseases (CVD), high blood pressure & PCOS. In contrast to GO, WHO emphasises AO as a superior CVD risk indicator & suggests additional steps like WHR for risk identification. Saturated & trans-fat-rich unhealthy diets are a factor in AO. Management of obesity benefits from dietary adjustments & insulin sensitizers, taxing fats & sugary drinks can be potential solutions for public health. In order to reduce the risk of CVD, physicians must create customised action plans. Conclusion: In comparison to general obesity, abdominal obesity is associated with a greater death rate & a better prognosis for cardiovascular illnesses & metabolic problems.


Keywords

Abdominal Obesity, Metabolic Risk, Cardiovascular Diseases